Jeff Zhang

CEO

Aubrak Therapeutics

Short Biography

Dr Jeff Zhang has extensive working experience in new drug discovery and development and understands the development trend of the global pharmaceutical industry. During his tenure in many multinational pharmaceutical companies, he led or participated in the invention of dozens of new compounds that can be used to treat a variety of diseases, such as analgesia, diabetes, obesity, cardiovascular, neurodegeneration, cancer and immune system diseases. Among them, nine drugs have been successfully approved and marketed. Worked at a number of well-known multinational pharmaceutical companies, such as Pfizer, GlaxoSmithKline and Novartis, for 28 years. Served as Chief Scientific Officer (CSO) of Youngene Therapeutics, and currently serves as Chief Executive Officer (CEO) of Aubrak Therapeutics.  He graduated from Shanghai Institute of Materia Medica with a Ph.D degree in organic chemistry and had postdoctoral fellowship at Vanderbilt University.